[Silent myocardial ischemia before and after revascularization].

Pol Merkur Lekarski

III Kliniki Kardiologii SI. A.M. w Katowicach.

Published: August 1996

In 82 patients with unstable ischemic heart disease (IHD) before and after revascularisation (percutaneous transluminal coronary angioplasty-PTCA-in 11 patients and coronary artery bypass graft-CABG-in 71 patients) silent ischemia incidence was observed. In these patients before and after operation election fraction (EF) and wall motion score index (IK) were compared echocardiographically as well as physical ability according to Bruce protocol in treadmill exercise test. Data (EF and IK and exercise test) before and after operation didn't change significantly. Silent ischemia was directed before operation in 17 patients (21.8%) and in 15 patients (19.4%) one month after those procedures.

Download full-text PDF

Source

Publication Analysis

Top Keywords

silent ischemia
8
exercise test
8
patients
6
[silent myocardial
4
myocardial ischemia
4
ischemia revascularization]
4
revascularization] patients
4
patients unstable
4
unstable ischemic
4
ischemic heart
4

Similar Publications

Background: Subarachnoid hemorrhage (SAH) is characterized by intense central inflammation, leading to substantial post-hemorrhagic complications such as vasospasm and delayed cerebral ischemia. Given the anti-inflammatory effect of transcutaneous auricular vagus nerve stimulation (taVNS) and its ability to promote brain plasticity, taVNS has emerged as a promising therapeutic option for SAH patients. However, the effects of taVNS on cardiovascular dynamics in critically ill patients, like those with SAH, have not yet been investigated.

View Article and Find Full Text PDF

Aims: Atherosclerosis is a life-threatening disease that develops when a plaque builds up inside an artery and progresses silently. Identifying the early pathological changes and the biomarkers of atherosclerosis deserves attention. We aimed to systematically study and integrate the various metabolites of atherosclerosis in the level of disease to provide more evidences to support early prevention and treatment of atherosclerosis.

View Article and Find Full Text PDF

Objectives: Peripheral arterial disease (PAD) and coronary artery disease (CAD) are major contributors to global morbidity and mortality. Many PAD patients remain asymptomatic for CAD, which often leads to undetected coronary artery involvement. This hidden coronary disease poses significant risks, particularly following peripheral revascularization, as increased cardiac demand can precipitate complications.

View Article and Find Full Text PDF

Case report: Vein of Marshall-catheter ablation combined with left atrial appendage occlusion for treatment of atrial fibrillation.

Heliyon

October 2024

Department of Cardiology, The Third Affiliated Hospital of Shanghai University, The Wenzhou Third Clinical Institute Affiliated to Wenzhou Medical University, Wenzhou People's Hospital, Wenzhou, China.

Article Synopsis
  • * A 62-year-old man underwent a successful one-stop procedure that integrated ethanol infusion in the vein of Marshall, radiofrequency catheter ablation, and left atrial appendage occlusion.
  • * Follow-up results showed effective AF treatment with sinus rhythm and no silent ischemia, suggesting this innovative approach could be beneficial for patients with AF.
View Article and Find Full Text PDF

Introduction: Silent myocardial ischemia (SMI) is a significant concern for diabetic patients, often remaining undetected until severe complications arise. Prolonged hyperglycemia, poor glycemic control, and lifestyle factors contribute to its risk, with older adults and those with long-standing diabetes particularly vulnerable.

Objective: To assess the prevalence and predictors of SMI in adults with diabetes, emphasizing long-term management and monitoring.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!